Genetic clues may forecast multiple sclerosis after vision loss

NCT ID NCT07704294

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This observational study looks at whether combining genetic information with standard clinical data can better predict who will develop multiple sclerosis after a first episode of optic neuritis (inflammation of the optic nerve). Researchers will follow 180 people aged 16 and older who have had optic neuritis, collecting saliva for genetic analysis and reviewing medical records. The goal is to develop a prognostic tool that could help guide care and improve understanding of future health risks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a tool that helps doctors predict who will develop multiple sclerosis after optic neuritis, enabling earlier monitoring and care.
What could go wrong
This is an observational study, not a treatment trial. It may not find a strong enough link between genetics and MS risk to create a useful prediction tool.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Guy's and St Thomas' NHS Foundation Trust

    London, SE1 7EH, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • King's College Hospital NHS Foundation Trust

    London, SE5 9RS, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Moorfields Eye Hospital NHS Foundation Trust

    London, EC1V 2PD, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.